Ionis Pharmaceuticals Reaffirms Fiscal 2026 Financial Guidance
() -- Ionis Pharmaceuticals (IONS) reaffirmed its fiscal 2026 financial guidance, leaving unchanged the outlook issued with its first-quarter results, citing a regulatory filing on Friday. Copyright © 2026. All rights reserved. does not provide investment advice. Unauthorized reproduction is strictly prohibited.